Pyriproxyfen
CAS No. 95737-68-1
Pyriproxyfen( S-31183 )
Catalog No. M26802 CAS No. 95737-68-1
Pyriproxyfen is an insecticide that acts as a biomimetic of juvenile hormone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 28 | In Stock |
|
Biological Information
-
Product NamePyriproxyfen
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyriproxyfen is an insecticide that acts as a biomimetic of juvenile hormone.
-
DescriptionPyriproxyfen is an insecticide that acts as a biomimetic of juvenile hormone.(In Vivo):Zebrafish male adults were acutely exposed to 0.001, 0.01 and 0.1 μg/mL pyriproxyfen for 16 h. Mitochondrial respiration of brain tissues was assessed. ROS generation was estimated using H2DCF-DA and MitoSOX. Calcium transport was monitored by Calcium Green 5 N. NO synthesis activity was estimated using DAF-FM-DA. Brain acetylcholinesterase showed an in vivo IC20 of 0.30 μmol/L pyriproxyfen, and an IC50 of 92.5 μmol/L. The inhibitory effect on zbAChE activity was competitive-like. Respiratory control of Complex I/II decreased significantly after insecticide exposure. The MitoSOX test showed that O2- generation had a pyriproxyfen dose-dependent effect. Brain tissue lost 50% of Ca2+ uptake capacity at 0.1 μg/mL pyriproxyfen. Ca2+ release showed a clear mitochondrial impairment at lower pyriproxyfen exposures.
-
In Vitro——
-
In Vivo——
-
SynonymsS-31183
-
PathwayOthers
-
TargetOther Targets
-
RecptorCDK4/CyclinD1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number95737-68-1
-
Formula Weight321.376
-
Molecular FormulaC20H19NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (311.17 mM)
-
SMILESCC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neel Jasani, et al. Potent anticancer activity of an orally bioavailable small molecule, ON 013100, and its water soluble derivative, briciclib, a clinical-stage eIF4E-targeted agent. AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA.
molnova catalog
related products
-
FAPI-2
FAPI-2 is a specific inhibitor of fibroblast-activated protein based on the radiotracer FAP labeling. It has anticancer activity and can be used in the study of pancreatic cancer.
-
SEP-0371845
SEP-0371845 is a biochemical.
-
MC1742
MC1742 is an inhibitor of class I histone deacetylases (HDACs; IC50s = 0.1, 0.11, 0.02, and 0.61 μM for HDAC1, -2, -3, and -8, respectively) and class IIb HDACs (IC50s = 7 and 40 nM for HDAC6 and HDAC10, respectively).
Cart
sales@molnova.com